HOUSTON, Feb. 10, 2021 /PRNewswire/ -- Soliton, Inc.,
(Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary aesthetic platform technology,
today announced Brad Hauser,
President & CEO of Soliton, has been named as an Aesthetic
Industry Association (AIA) advisory board member.
"I am excited to be joining the Aesthetic Industry Association
advisory board as I believe this association provides substantial
thought leadership to the aesthetic industry," commented
Brad Hauser, President & CEO of
Soliton. "As Soliton continues to elevate the market and drive
towards commercialization, the learnings will create a real
symbiotic relationship between Soliton and the AIA."
"We are honored to accept Mr. Hauser to an AIA Board position,
given his resume which spans over 20 years in medical aesthetics
across several disruptive technologies," said Michael Moretti, Executive Director of AIA.
"I've personally known and worked with him during this time to
develop our industry in a very positive direction via legitimate
technologies backed by scientific evidence. I know that Mr. Hauser
will provide visionary leadership skills to the AIA and take a very
active role in shaping our future."
The Aesthetic Industry Association (AIA) is the first and only
member-driven organization dedicated to the long-term health,
sustainability, and development of the $14
Billion medical aesthetic industry. While hundreds of
suppliers and thousands of executives have made a very successful
career in this relatively young sector, until now they had no
focused industry association representing their future. Medical
Insight (MII) founded the AIA in 2019 to represent and protect the
broad interests of this vibrant global industry which is dedicated
to beauty and rejuvenation for a highly motivated consumer
population which includes virtually all demographic groups.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer
Center. The Company's first FDA cleared commercial product will use
rapid pulses of acoustic shockwaves as an accessory to lasers for
the removal of unwanted tattoos and the temporary improvement in
the appearance of cellulite. The Company is based in Houston, Texas, and is actively engaged in
bringing the Rapid Acoustic Pulse ("RAP") device to the market. The
Company believes this "Soliton" method has the potential to lower
tattoo removal costs for patients, while increasing profitability
to practitioners, compared to current laser removal methods.
The Company also believes the technology will provide the first
non-invasive acoustic technology to be able to target the
underlying cause of dimples and ridges in cellulite.
For more information about the Company, please
visit: http://www.soliton.com
Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, Section
21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995, which statements involve
risks and uncertainties. These statements relate to future
events, future expectations, plans and prospects. Although Soliton
believes that the expectations reflected in such forward-looking
statements are reasonable as of the date made, actual results or
outcomes may prove to be materially different from the expectations
expressed or implied by such forward-looking statements. Soliton
has attempted to identify forward-looking statements by terminology
including ''believes,'' ''estimates,'' ''anticipates,''
''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,''
''may,'' ''could,'' ''might,'' ''will,'' "would," ''should,''
''approximately'' or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are only predictions and involve known and unknown
risks, uncertainties, and other factors, including those discussed
in our filings with the Securities and Exchange Commission ("SEC"),
including under the heading " Risk Factors" in our most recently
filed Form 10-K filed with the SEC and as updated in our Form 10-Q
filings and in our other filings with the SEC. Any
forward-looking statements contained in this release speak only as
of its date. Soliton undertakes no obligation to update any
forward-looking statements contained in this release to reflect
events or circumstances occurring after its date or to reflect the
occurrence of unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-president--ceo-brad-hauser-named-as-aesthetic-industry-association-advisory-board-member-301225301.html
SOURCE Soliton, Inc.